GI Paradox: In the labyrinthine world of type 2 diabetes, where blood sugar levels dance a volatile tango, lies a curious paradox: the tale of Gastric Inhibitory Polypeptide (GIP). This gut hormone, initially hailed as a beacon of hope for glycemic control, has revealed a Janus-faced nature, wielding both the power to lower and elevate … Continue reading Gastric Inhibitory Polypeptide and the Double-Edged Sword in Type 2 Diabetes